A retrospective pilot clinical study on time domain multi-wavelength (635 to 1060 nm) optical mammography was exploited to assess collagen as a breast-cancer risk factor on a total of 109 subjects (53 healthy and 56 with malignant lesions). An increased cancer occurrence is observed on the 15% subset of patients with higher age-matched collagen content. Further, a similar clustering based on the percentage breast density leads to a different set of patients, possibly indicating collagen as a new independent breast cancer risk factor. If confirmed statistically and on larger numbers, these results could have huge impact on personalized diagnostics, health care systems, as well as on basic research.
INTRODUCTION
The identification of risk factors for breast cancer is a relevant open quest. The ability to identify clusters of subjects at high risk permits to foresee personalized diagnostics paths on smaller groups -not sustainable in population-wide screening programs. Indeed, the early diagnosis of breast cancer (size <1cm, no lymph node involvement) leads to an impressive 95% complete remission rate. Breast density is recognized as a strong and independent risk factor for breast cancer and is usually quantified by X-ray mammography. Recently, optical techniques have been shown to offer a valid non-invasive and possibly cost-effective alternative for the assessment of breast density even at young age [1] [2] [3] .
In this paper we explore an even more ambitious goal, which is to investigate whether optical techniques can be used directly to assess breast cancer risk factors and not just indirectly by correlation with mammographic breast density. More specifically, we address collagen -quantified by time-resolved diffuse optical spectroscopy 4 -as a potential independent risk factor for breast cancer 5 .
MATERIALS AND METHODS

Instrument set-up
Time-resolved transmittance scans are performed at 7 wavelengths (635, 685, 785, 905, 930, 975, 1060 nm) using pulsed diode lasers and time-correlated single photon counting 4 . The compressed breast is scanned continuously recording data every millimiter. The central region of the breast, far from boundaries, is used for assessment of breast optical properties. A schematics of the instrument is shown in Fig. 1. 
Patient study
For the purpose of this investigation, a total of 109 patients were included following criteria of i) availability of digital mammography for percentage breast density assessment; ii) absence of technical failure or limitations (e.g. poor signal);
iii) exclusion of patients with benign lesions or not clearly classified malignant lesions (e.g. DCIS). Two subsets of 53 healthy subjects (normal) and 56 patients bearing a malignant lesion (cancer) were extracted.
Data analysis
Tissue composition and structure is obtained directly from time-resolved transmittance curves using a spectrally constrained global fitting procedure on the key absorber concentrations (oxy-and deoxy-hemoglobin, water, lipids, and collagen) together with the scattering amplitude a and power b. The collagen absorption spectrum was obtained using a broadband time-resolved diffuse optical spectrometer 6 on bovine tendon collagen type I powder purchased from Sigma 7 .
An experienced radiologist evaluated percentage mammographic density using a fully automated procedure 8 .
Age-matched distributions of collagen and density are obtained by dividing both the collagen content and the percentage density by the corresponding theoretical age-matched value obtained by a linear interpolation on the distribution of normal subjects. 
RESULTS AND DISCUSSION
In principle, the investigation of a new potential breast cancer risk factor would require a long longitudinal study involving a high number of subjects to understand whether factor X detected at age Y is correlated with a later occurrence of cancer. Clearly, such a huge trial can be undertaken only once the initial hypothesis has been explored on a much smaller scale. The approach we pursue here for a first insight is to address the question retrospectively, i.e. to find out whether subjects bearing a breast lesion have any signs in their healthy breast tissue suggesting a higher risk factor. For this purpose, we exploited the outcome of a clinical study on optical mammography initially designed for the aim of differentiating optically malignant from benign lesions 9 and assessing breast density by optical means 1 . Just two groups are identified here, i.e. normal (healthy subject) and cancer (bearing a malignant lesion). There is a slightly higher mean collagen content in the cancer group as compared to the normal one, yet these differences are not significant considering the high dispersion of the data. At a first sight one could conclude that the chance to use collagen as a breast cancer risk factor is deemed to fail. Nevertheless, a similar pattern is observed also for the percentage density, for which correlation with higher cancer risk is clearly demonstrated in literature. The clue here is that the number of subjects that get cancer because of their higher breast density is just a fraction of the total population. Thus its impact on the mean values is quite diluted.
In order to investigate the possible role of collagen as a risk factor for a specific sub-group of the whole population, we mimicked -at first order -the known results reported for breast density. First, age-matched effective collagen values were derived dividing the measured quantity by the theoretical average age-matched estimates as described in Section 2.3. Then, the cohort of subjects with a higher collagen content are compared to the distribution observed on the whole population. Figure 3 shows the plot of the occurrence of cancer (red solid line) and normal (blue dotted line) lesions in the cohort of subjects with the highest age-matched collagen content. The threshold indicates the percentage of the total population that are included in the cohort. For a threshold around 15%, the high-collagen cohort exhibits the largest incidence of cancer lesions (about 80%) as compared to the total population included in this study that have a cancer incidence of 50%. This increase is large since we have to consider that the maximum incidence is necessarily saturated at 100%.
To translate these numbers into an increased risk factor for a standard population, where the average occurrence of cancer lesions is obviously much lower, a proper non-linear model must be applied. Also, more refined analysis is needed to assess the statistical significance of these results. 
CONCLUSION
In conclusion, in a retrospective pilot clinical study involving 109 patients we show that, sorting subjects on the basis of age-matched collagen content, it is possible to identify an increased cancer occurrence as compared to the reference value on the whole population considered in the study. This means that collagen could be considered for screening purposes to identity women at higher risk for breast cancer. This study is still preliminary and will be further investigated on statistical basis and compared with results obtained using breast density as classification index. These results are consistent with what inferred from recent studies showing possible involvement of collagen in breast cancer onset and progression 4 , and will open new screening potential if confirmed on a larger scale. Impressive growth on photonics components are now opening the way to deployment of small, cost-effective, and portable time-resolved diffuse optics devices 10, 11 , which could be used in simple and operator independent breast cancer risk screening programs at the level of the general practitioner. 
